.

Make Better Decisions

  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Accenture
Novartis
Johnson and Johnson
US Army
Healthtrust
Medtronic
Argus Health
Express Scripts
Covington

Generated: December 12, 2017

DrugPatentWatch Database Preview

Fluvoxamine maleate - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for fluvoxamine maleate and what is the scope of fluvoxamine maleate freedom to operate?

Fluvoxamine maleate
is the generic ingredient in three branded drugs marketed by Actavis Elizabeth, Anchen Pharms, Torrent Pharms Ltd, Jazz Pharms, Ani Pharms Inc, Apotex, Eci Pharms Llc, Mylan, Sun Pharm Industries, Synthon Pharms, Teva, Upsher-smith Labs, Watson Labs, Ani Pharms, and Solvay, and is included in nineteen NDAs. There is one patent protecting this compound and two Paragraph IV challenges. Additional information is available in the individual branded drug profile pages.

Fluvoxamine maleate has twenty-four patent family members in eighteen countries.

There are eleven drug master file entries for fluvoxamine maleate. Fourteen suppliers are listed for this compound.

Pharmacology for fluvoxamine maleate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Exclusivity Expiration
SolvayLUVOXfluvoxamine maleateTABLET;ORAL020243-002Dec 5, 1994DISCNYesNo► Subscribe► Subscribe► Subscribe► Subscribe
Torrent Pharms LtdFLUVOXAMINE MALEATEfluvoxamine maleateCAPSULE, EXTENDED RELEASE;ORAL203240-002Oct 31, 2014ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Eci Pharms LlcFLUVOXAMINE MALEATEfluvoxamine maleateTABLET;ORAL075900-003Feb 23, 2006DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Watson LabsFLUVOXAMINE MALEATEfluvoxamine maleateTABLET;ORAL075894-003Apr 18, 2001DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Synthon PharmsFLUVOXAMINE MALEATEfluvoxamine maleateTABLET;ORAL075899-003Jan 17, 2001DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Actavis ElizabethFLUVOXAMINE MALEATEfluvoxamine maleateCAPSULE, EXTENDED RELEASE;ORAL091482-002Nov 18, 2013ABRXNoYes► Subscribe► Subscribe► Subscribe► Subscribe
Watson LabsFLUVOXAMINE MALEATEfluvoxamine maleateTABLET;ORAL075894-001Apr 18, 2001DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
MylanFLUVOXAMINE MALEATEfluvoxamine maleateTABLET;ORAL075950-002Oct 15, 2001DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Ani PharmsLUVOXfluvoxamine maleateTABLET;ORAL021519-002Dec 20, 2007ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Actavis ElizabethFLUVOXAMINE MALEATEfluvoxamine maleateTABLET;ORAL075901-001Dec 28, 2000DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: fluvoxamine maleate

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
SolvayLUVOXfluvoxamine maleateTABLET;ORAL020243-001Dec 5, 1994► Subscribe► Subscribe
SolvayLUVOXfluvoxamine maleateTABLET;ORAL020243-004Dec 5, 1994► Subscribe► Subscribe
SolvayLUVOXfluvoxamine maleateTABLET;ORAL020243-003Dec 5, 1994► Subscribe► Subscribe
SolvayLUVOXfluvoxamine maleateTABLET;ORAL020243-002Dec 5, 1994► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Ingredient: fluvoxamine maleate

Country Document Number Estimated Expiration
Australia782059► Subscribe
Japan2003500348► Subscribe
South Africa200110401► Subscribe
European Patent Office1178780► Subscribe
World Intellectual Property Organization (WIPO)0071099► Subscribe
Ireland990406► Subscribe
Germany60035579► Subscribe
Denmark1178780► Subscribe
Australia4426700► Subscribe
Czech Republic20014618► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Dow
Cerilliant
Baxter
Chubb
Argus Health
Express Scripts
Harvard Business School
Deloitte
Julphar
Federal Trade Commission

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot